U.S. Physical Therapy (NYSE:USPH) Rating Reiterated by Barrington Research

Barrington Research reissued their outperform rating on shares of U.S. Physical Therapy (NYSE:USPH - Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a $108.00 price target on the stock.

USPH has been the topic of several other reports. Bank of America restated a neutral rating and set a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday. StockNews.com raised U.S. Physical Therapy from a sell rating to a hold rating in a research note on Wednesday, August 21st.

U.S. Physical Therapy Stock Up 0.9 %

Shares of NYSE:USPH traded up $0.72 during midday trading on Wednesday, hitting $78.20. 143,186 shares of the stock were exchanged, compared to its average volume of 88,507. The company has a market capitalization of $1.18 billion, a PE ratio of 63.68, a P/E/G ratio of 3.97 and a beta of 1.39. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. The business's fifty day simple moving average is $85.15 and its two-hundred day simple moving average is $94.85.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). The business had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. U.S. Physical Therapy's revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.76 EPS. As a group, research analysts predict that U.S. Physical Therapy will post 2.51 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy's dividend payout ratio is 143.09%.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares of the company's stock, valued at $580,635. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, COO Graham D. Reeve sold 1,724 shares of the business's stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the transaction, the director now owns 18,904 shares of the company's stock, valued at $1,627,445.36. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. 1.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of large investors have recently bought and sold shares of the business. Silvercrest Asset Management Group LLC acquired a new stake in shares of U.S. Physical Therapy in the first quarter valued at $8,158,000. Harbor Capital Advisors Inc. raised its stake in shares of U.S. Physical Therapy by 292.5% in the second quarter. Harbor Capital Advisors Inc. now owns 7,584 shares of the company's stock worth $701,000 after acquiring an additional 5,652 shares during the last quarter. Norden Group LLC raised its stake in shares of U.S. Physical Therapy by 1,841.6% in the first quarter. Norden Group LLC now owns 63,938 shares of the company's stock worth $7,217,000 after acquiring an additional 60,645 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of U.S. Physical Therapy by 1.0% during the first quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company's stock worth $121,065,000 after purchasing an additional 10,175 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co grew its stake in shares of U.S. Physical Therapy by 5.8% during the first quarter. CANADA LIFE ASSURANCE Co now owns 12,642 shares of the company's stock valued at $1,423,000 after purchasing an additional 696 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.